Alzheimer's disease - PubMed (original) (raw)
Review
. 2011 Mar 19;377(9770):1019-31.
doi: 10.1016/S0140-6736(10)61349-9. Epub 2011 Mar 1.
Affiliations
- PMID: 21371747
- DOI: 10.1016/S0140-6736(10)61349-9
Free article
Review
Alzheimer's disease
Clive Ballard et al. Lancet. 2011.
Free article
Abstract
An estimated 24 million people worldwide have dementia, the majority of whom are thought to have Alzheimer's disease. Thus, Alzheimer's disease represents a major public health concern and has been identified as a research priority. Although there are licensed treatments that can alleviate symptoms of Alzheimer's disease, there is a pressing need to improve our understanding of pathogenesis to enable development of disease-modifying treatments. Methods for improving diagnosis are also moving forward, but a better consensus is needed for development of a panel of biological and neuroimaging biomarkers that support clinical diagnosis. There is now strong evidence of potential risk and protective factors for Alzheimer's disease, dementia, and cognitive decline, but further work is needed to understand these better and to establish whether interventions can substantially lower these risks. In this Seminar, we provide an overview of recent evidence regarding the epidemiology, pathogenesis, diagnosis, and treatment of Alzheimer's disease, and discuss potential ways to reduce the risk of developing the disease.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
- Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
Thal DR, Fändrich M. Thal DR, et al. Acta Neuropathol. 2015 Feb;129(2):163-5. doi: 10.1007/s00401-015-1387-2. Acta Neuropathol. 2015. PMID: 25600324 No abstract available. - Beyond diagnosis: what biomarkers are teaching us about the "bio"logy of Alzheimer disease.
Rabinovici GD, Roberson ED. Rabinovici GD, et al. Ann Neurol. 2010 Mar;67(3):283-5. doi: 10.1002/ana.22020. Ann Neurol. 2010. PMID: 20373338 No abstract available. - Alzheimer's disease.
Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM. Scheltens P, et al. Lancet. 2016 Jul 30;388(10043):505-17. doi: 10.1016/S0140-6736(15)01124-1. Epub 2016 Feb 24. Lancet. 2016. PMID: 26921134 Review. - Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.
Mondragón-Rodríguez S, Basurto-Islas G, Lee HG, Perry G, Zhu X, Castellani RJ, Smith MA. Mondragón-Rodríguez S, et al. Expert Rev Neurother. 2010 May;10(5):683-91. doi: 10.1586/ern.10.27. Expert Rev Neurother. 2010. PMID: 20420489 Free PMC article. Review. - Imaging as a strategy for premortem diagnosis and staging of tauopathies.
Kim S, Jensen JR, Cisek K, Funk KE, Naphade S, Schafer K, Kuret J. Kim S, et al. Curr Alzheimer Res. 2010 May;7(3):230-4. doi: 10.2174/156720510791050894. Curr Alzheimer Res. 2010. PMID: 20088805 Review.
Cited by
- Molecular landscape of the overlap between Alzheimer's disease and somatic insulin-related diseases.
Ruisch IH, Widomska J, De Witte W, Mota NR, Fanelli G, Van Gils V, Jansen WJ, Vos SJB, Fóthi A, Barta C, Berkel S, Alam KA, Martinez A, Haavik J, O'Leary A, Slattery D, Sullivan M, Glennon J, Buitelaar JK, Bralten J, Franke B, Poelmans G. Ruisch IH, et al. Alzheimers Res Ther. 2024 Oct 28;16(1):239. doi: 10.1186/s13195-024-01609-2. Alzheimers Res Ther. 2024. PMID: 39465382 Free PMC article. - Burden of neurological diseases in Asia from 1990 to 2019: a systematic analysis using the Global Burden of Disease Study data.
Kang S, Eum S, Chang Y, Koyanagi A, Jacob L, Smith L, Shin JI, Song TJ. Kang S, et al. BMJ Open. 2022 Sep 7;12(9):e059548. doi: 10.1136/bmjopen-2021-059548. BMJ Open. 2022. PMID: 36265073 Free PMC article. - Assessment of potential targets for deep brain stimulation in patients with Alzheimer's disease.
Sharma M, Deogaonkar M, Rezai A. Sharma M, et al. J Clin Med Res. 2015 Jul;7(7):501-5. doi: 10.14740/jocmr2127w. Epub 2015 May 8. J Clin Med Res. 2015. PMID: 26015813 Free PMC article. Review. - Transcranial alternating current stimulation (tACS) at gamma frequency: an up-and-coming tool to modify the progression of Alzheimer's Disease.
De Paolis ML, Paoletti I, Zaccone C, Capone F, D'Amelio M, Krashia P. De Paolis ML, et al. Transl Neurodegener. 2024 Jun 27;13(1):33. doi: 10.1186/s40035-024-00423-y. Transl Neurodegener. 2024. PMID: 38926897 Free PMC article. Review. - Increased Risk of Dementia in Patients With Acute Organophosphate and Carbamate Poisoning: A Nationwide Population-Based Cohort Study.
Lin JN, Lin CL, Lin MC, Lai CH, Lin HH, Yang CH, Kao CH. Lin JN, et al. Medicine (Baltimore). 2015 Jul;94(29):e1187. doi: 10.1097/MD.0000000000001187. Medicine (Baltimore). 2015. PMID: 26200627 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical